Horizon Therapeutics Public Ltd Co

Summit Financial, LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/7/2023

Shares

15,842

Value ($000)

1,833

Weight

0.1%

2023 Q2 - 2023 Q3 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/7/2023	1,833	0.1%	15,842	9/30/2023
2023 Q2	8/11/2023	1,784	0.1%	17,346	6/30/2023